SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 73.92 |
| Enterprise Value ($M) | 42.80 |
| Book Value ($M) | 80.49 |
| Book Value / Share | 2.79 |
| Price / Book | 0.92 |
| NCAV ($M) | 80.14 |
| NCAV / Share | 2.78 |
| Price / NCAV | 0.92 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.04 |
| Return on Assets (ROA) | -0.60 |
| Return on Equity (ROE) | -0.67 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.78 |
| Current Ratio | 8.78 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 90.61 |
| Assets | 90.96 |
| Liabilities | 10.47 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Baker Bros. Advisors Lp | 2.20 | -62.57 | |
| 13D/A | Ra Capital Management, L.p. | 32.00 | 11.16 | |
| 13D/A | Sofinnova Venture Partners X, L.P. | 13.80 | 0.63 | |
| 13G/A | Cormorant Asset Management, LP | 4.38 | -38.09 | |
| 13G/A | Citadel Advisors Llc | 0.00 | ||
| 13G | TCG Crossover GP I, LLC | 8.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 73,198 | 499,312 | 14.66 | |
| 47,454 | 363,063 | 13.07 | |
| 75,939 | 304,893 | 24.91 | |
| 15,249 | 123,423 | 12.36 | |
| 17,373 | 174,918 | 9.93 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AURA – Aura Biosciences, Inc. | AVBP – ArriVent BioPharma, Inc. |
| AVDL – Avadel Pharmaceuticals plc | AXSM – Axsome Therapeutics, Inc. |
| BCAB – BioAtla, Inc. |
Financial data and stock pages provided by
Fintel.io